Global Pediatric Development of Drugs, Biologics, and Medical Devices takes an in-depth look at creating and implementing a global regulatory strategy for bringing pediatric drug products and ...

Changes in the regulatory environment in the United States and European Union have the potential to advance the concept of precision medicine to children with cancer. Preclinical testing of targeted ...

Unfortunately, this book can't be printed from the OpenBook. If you need to print pages from this book, we recommend downloading it as a PDF. Visit NAP.edu/10766 to get more information about this ...

“Is your baby smiling at you?” “Has your baby started crawling?” “Are they babbling?” “Can they wave and play peek-a-boo?” These are the questions I frequently ask parents of my patients as I observe ...

In addition to providing developmental medicine consultations for children referred locally, regionally, nationally, and internationally, the Meyer Center for Developmental Pediatrics has always ...

The Saint Louis University Division of Developmental Pediatrics provides diagnostic evaluations, follow-ups, support and advocacy in the community for children and their families. As part of the ...

On May 17, the U.S. Food & Drug Administration (“FDA”) issued two important draft guidance documents, which clarify the agency’s approach to requirements and incentives in the realm of pediatric drug ...

Reading is more than just a silent activity for kids; it is one of the best methods for developing the brain during childhood. Reading can help children think, imagine, reason, or communicate based on ...

Despite improved outcomes in newly diagnosed pediatric AML, relapsed disease remains a therapeutic challenge. Factors contributing to slow progress in improving outcomes include inherent challenges in ...